Cosmos Health Inc (NASDAQ: COSM)’s stock price has dropped by -4.50 in relation to previous closing price of 0.66. Nevertheless, the company has seen a loss of -3.96% in its stock price over the last five trading days. accesswire.com reported 2024-12-26 that CHICAGO, IL / ACCESSWIRE / December 26, 2024 / Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology at the Company’s Research and Development division. Professor Trafalis currently serves as a Professor of Pharmacology and Clinical Pharmacology at the Faculty of Medicine, National and Kapodistrian University of Athens.
Is It Worth Investing in Cosmos Health Inc (NASDAQ: COSM) Right Now?
COSM has 36-month beta value of 3.17. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for COSM is 19.65M, and currently, short sellers hold a 1.78% ratio of that float. The average trading volume of COSM on December 27, 2024 was 237.86K shares.
COSM’s Market Performance
COSM stock saw a decrease of -3.96% in the past week, with a monthly decline of -15.98% and a quarterly a decrease of -27.59%. The volatility ratio for the week is 11.10%, and the volatility levels for the last 30 days are 8.13% for Cosmos Health Inc (COSM). The simple moving average for the past 20 days is -12.85% for COSM’s stock, with a -25.02% simple moving average for the past 200 days.
COSM Trading at -13.63% from the 50-Day Moving Average
After a stumble in the market that brought COSM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.82% of loss for the given period.
Volatility was left at 8.13%, however, over the last 30 days, the volatility rate increased by 11.10%, as shares sank -19.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.96% lower at present.
During the last 5 trading sessions, COSM fell by -3.96%, which changed the moving average for the period of 200-days by -19.75% in comparison to the 20-day moving average, which settled at $0.7229. In addition, Cosmos Health Inc saw -55.32% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at COSM starting from Terzis Georgios, who purchase 85,778 shares at the price of $0.58 back on Dec 20 ’24. After this action, Terzis Georgios now owns 727,263 shares of Cosmos Health Inc, valued at $50,000 using the latest closing price.
Siokas Grigorios, the Chief Executive Officer of Cosmos Health Inc, purchase 257,334 shares at $0.58 during a trade that took place back on Dec 20 ’24, which means that Siokas Grigorios is holding 3,774,314 shares at $150,000 based on the most recent closing price.
Stock Fundamentals for COSM
Current profitability levels for the company are sitting at:
- -0.36 for the present operating margin
- 0.08 for the gross margin
The net margin for Cosmos Health Inc stands at -0.36. The total capital return value is set at -0.51. Equity return is now at value -46.31, with -26.60 for asset returns.
Based on Cosmos Health Inc (COSM), the company’s capital structure generated 0.23 points at debt to capital in total, while cash flow to debt ratio is standing at -0.35. The debt to equity ratio resting at 0.29. The interest coverage ratio of the stock is -19.59.
Currently, EBITDA for the company is -17.06 million with net debt to EBITDA at -0.42. When we switch over and look at the enterprise to sales, we see a ratio of 0.4. The receivables turnover for the company is 3.21for trailing twelve months and the total asset turnover is 0.87. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.44.
Conclusion
To put it simply, Cosmos Health Inc (COSM) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
